Rb plays a role in survival of Abl-dependent human tumor cells as a downstream effector of Abl tyrosine kinase-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rb plays a role in survival of Abl-dependent human tumor cells as a downstream effector of Abl tyrosine kinase

Published:2005-09-19 Issue:4 Volume:25 Page:493-502
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Nagano K,Itagaki C,Izumi T,Nunomura K,Soda Y,Tani K,Takahashi N,Takenawa T,Isobe T

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1208996.pdf

Reference35 articles.

1. Baltimore D, Ren R, Cheng G, Alexandropoulos K, Cicchetti P . (1995). Ann NY Acad Sci 758: 339–344.

2. Baskaran R, Wood LD, Whitaker LL, Canman CE, Morgan SE, Xu Y et al. (1997). Nature 387: 516–519.

3. Bowen C, Birrer M, Gelmann EP . (2002). J Biol Chem 277: 44969–44979.

4. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T . (1998). Nature 391: 597–601.

5. Calabretta B, Perrotti D . (2004). Blood 103: 4010–4022.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interferon-γ inducible factor 16 (IFI16) restricts adeno-associated virus type 2 (AAV2) transduction in an immune-modulatory independent way;Journal of Virology;2024-07-23

2. The interferon-ɣ inducible factor 16 (IFI16) restricts adeno-associated virus serotype 2 (AAV2) transduction in an immune-modulatory independent way;2024-01-24

3. Post-translational modifications on the retinoblastoma protein;Journal of Biomedical Science;2022-06-01

4. Understanding Retinoblastoma Post-Translational Regulation for the Design of Targeted Cancer Therapies;Cancers;2022-02-28

5. Chronic myeloid leukemia versus acute myeloid leukemia in patients with retinoblastoma;Oman Journal of Ophthalmology;2021-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3